Hostname: page-component-7bb8b95d7b-qxsvm Total loading time: 0 Render date: 2024-09-16T20:42:14.588Z Has data issue: false hasContentIssue false

Biological Warfare and Infection Control

Published online by Cambridge University Press:  21 March 2023

Mary D. Nettleman*
Affiliation:
Department of Internal Medicine, the Division of General Medicine, Clinical Epidemiology, and Health Services Research, The University of Iowa Hospitals and Clinics, Iowa City, Iowa
*
University of Iowa Hospitals and Clinics, C41 GH, Iowa City, IA 52242

Extract

Though biological weapons were outlawed in 1925 by the Geneva Convention and though research, development, and stockpiling of such weapons were forbidden by the Biological Weapons Convention in 1972, the threat of biological warfare has not been eradicated. A wide variety of agents have been considered as possible weapons. In addition to their devastating effect on the battlefield, some have potential for nosocomial spread in US hospitals that care for victims of biological warfare. The following is a brief review of the history of germ warfare, a description of selected agents under consideration, and a discussion of the potential impact of biological weapons on hospital infection control.

Biological warfare has been attempted many times in past centuries and is not a concept unique to the war in the Persian Gulf. Poisoning wells by throwing dead bodies into them was not uncommon in the Middle Ages. During the 14th century conflict in Crimea, plague victims were catapulted into the besieged city of Kaffa by the Tartar army. Whether aided by this or not, plague soon broke out and the city surrendered. Escaping citizens and returning soldiers soon spread the disease to much of Europe. In another example, blankets from smallpox victims were considered as potential weapons against American Indians by British colonial commanders in the 18th century. More recently, Japan purportedly investigated biological weapons to spread plague, cholera, yellow fever, and anthrax during World War II. Attempts in earlier centuries usually were unsuccessful due to the lack of knowledge about disease vectors and etiological agents. Only with the advent of modern microbiological techniques has intentional biological warfare been possible on an organized and vast scale.

Type
Emporiatrics
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1991

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Humphrey, JH. Biological weapons-banned but gone forever? Medicine and War. 1987;3:2330.CrossRefGoogle ScholarPubMed
2. Doyle, RJ, Lee, NC. Microbes, warfare, religion, and human institutions. Can J Microbiol. 1986;32:193200.CrossRefGoogle ScholarPubMed
3. Tuchman, B. A Distant Mirror. New York, NY: Alfred A. Knopf; 1978.Google Scholar
4. Capps, L, Vermund, SH, Johnsen, C. Smallpox and biological warfare: the case for abandoning vaccination of military personnel. Am J Public Health. 1986;76:12291231.CrossRefGoogle ScholarPubMed
5. Cowdrey, AE. ‘Germ warfare’ and public health in the Korean conflict. J Hist Med Allied Sci. 1984:153172.Google Scholar
6. Medvedev, ZA. AIDS virus infection: a Soviet view of its origin.] Royal Soc Med. 1986;79:494495.Google ScholarPubMed
7. Manchee, RJ, Broster, MG, Anderson, IS, Henstridge, RM, Melling, J. Decontamination of Bacillus anthracis on Gruinard Island? Nature. 1983;303:239240.CrossRefGoogle ScholarPubMed
8. Livingstone, NC, Douglass, JD. CBW: The Poor Man's Atomic Bomb. Cambridge, Mass: Institute of Foreign Policy Analysis, Inc; 1984.Google Scholar
9. Wenzel, RP, Nettleman, MD. Smallpox vaccination for investigators using vaccinia recombinants. Lancet. 1989;ii:630631.CrossRefGoogle Scholar
10. Neff, JM, Lane, JM, Pert, JH, Moore, R, Milar, JD, Henderson, DA. Complications of smallpox vaccination I: national survey in the United States. 1963. N Engl J Med. 1967;276:125132.CrossRefGoogle ScholarPubMed
11. Huxsoll, DL, Patrick, WC, Parrott, CD. Veterinary services in biological disasters. J Am Vetinar Med Assoc. 1987;190:714723.Google ScholarPubMed
12. Nalin, DR, Sultana, B, Sahunja, R, et al. Survival of a patient with intestinal anthrax. Am J Med. 1977;62:130132.CrossRefGoogle ScholarPubMed
13. Brachman, PS, Gold, H, Plotkin, SA, Fekely, R, Werrin, M, Ingraham, NR. Field evaluation of a human anthraxvaccine. Am J Public Health. 1962;52:632645.CrossRefGoogle Scholar
14. Manson-Bahr, PEC, Bell, DR. Manson's Tropical Diseases. Landon, England: Bailliere Tindall; 1987.Google Scholar
15. Garner, JS, Simmons, BP Guideline for isolation precautions in hospitals. Infect Control. 1983;4:247325.Google ScholarPubMed
16. Benenson, AS. Control of Communicable Disease in Man. Washington, DC: American Public Health Association; 1990.Google Scholar
17. Centers for Disease Control. Plague vaccine. MMWR. 1982;31:301304.Google Scholar
18. Centers for Disease Control. Human plague--United States, 1988. MMWR. 1988;37:653656.Google Scholar
19. Asperilla, MO, Smego, RA, Scott, LK. Quinolone antibiotics in the treatment of Salmonella infections. Rev Infect Dis. 1990;12:873889.CrossRefGoogle ScholarPubMed
20. Rodriguez-Noriega, E, Andrade-Villanueva, J, Amay-Tapia, G. Quinolones in the treatment of Salmonella carriers. Rev Infect Dis. 1989;11(suppl):S1179S1187.CrossRefGoogle ScholarPubMed
21. Woodruff, BA, Pavia, AT, Blake, PA A new look at typhoid vaccination: information for the practicing physician. JAMA. 1991;265:756759.CrossRefGoogle Scholar
22. Capps, L, Vermund, SH, Johnsen, C. Smallpox and biological warfare: the case for abandoning vaccination of military personnel. Am J Public Health. 1986;76:12291231.CrossRefGoogle ScholarPubMed
23. Huxsoll, DL, Parrot, CD, Patrick, WC. Medicine in defense against biological warfare. JAMA. 1989;262:677679.CrossRefGoogle ScholarPubMed
24. Burke, DS. Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia. J Infect Dis. 1977;135:5560.CrossRefGoogle ScholarPubMed
25. Talmage, DW, Alexander, M, Carpenter, RL, et al. Protection Against Trichothecene Mycotoxins. Washington, DC: National Academy Press; 1983.Google Scholar